1264737-26-9

1264737-26-9 structure
1264737-26-9 structure
  • Name: Gatipotuzumab
  • Chemical Name: Gatipotuzumab
  • CAS Number: 1264737-26-9
  • Molecular Formula:
  • Molecular Weight:
  • Catalog: Research Areas Cancer
  • Create Date: 2023-01-25 08:15:28
  • Modify Date: 2024-04-07 15:35:31
  • Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC)[1][2].

Name Gatipotuzumab
Description Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC)[1][2].
Related Catalog
Target

MUC1[1]

In Vitro Gatipotuzumab (PankoMab) 在 PDTRP 序列的 T 位点被 GalNAcα 糖基化时,强烈结合由 30 个氨基酸组成的 1.5 TRs 的短 MUC1 肽,但如果相同的肽没有糖基化时则不会结合[2]。 Gatipotuzumab (PankoMab) (1 h) 对肿瘤细胞具有高亲和力 (对 NM-D4、ZR75-1、MCF-7 和 T-47D 的 KD 分别为 0.91、3.03、3.84 和 7.14 nM)[2]。 Gatipotuzumab (PankoMab) (0-5 μg/mL; 4 h) 显示特异性的抗肿瘤抗体依赖细胞细胞毒活性[2]。
References

[1]. Macchini M, et al. Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 gatipotuzumab (GAT) with the anti-EGFR tomuzotuximab (TO) or panitumumab in patients with refractory solid tumors. European Journal of Cancer, 2020, 138: S5-S6.

[2]. Danielczyk A, et al. PankoMab: a potent new generation anti-tumour MUC1 antibody. Cancer Immunol Immunother. 2006 Nov;55(11):1337-47.  

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.